ClinicalTrials.gg
Not yet recruitingNCT07903779SCREENS-BPUpdated Oct 29, 2026

Effects of Smartphone Use and Television Viewing on Standardized BP Measurement: The SCREENS-BP Study

An interventional study of Standardized office blood pressure measurements in Hypertension, sponsored by Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal. Not yet recruiting at 2 sites in 2 countries. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-29.

Sponsored by Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal · Not applicable, Interventional, and Diagnostic

Updated Oct 29, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
96
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The SCREENS-BP study is a randomized crossover study evaluating the effects of smartphone use and television viewing on blood pressure (BP) measurements in 96 adults.

Each participant will undergo four sets of automated BP measurements under standardized conditions. The first three sets will be performed in random order: without distractions, while actively using a smartphone, and while watching a standardized television video. A fourth set without distractions will be performed at the end. Each set will consist of a two-minute walk, five minutes of rest followed by three BP measurements taken at one-minute intervals, without staff present.

The primary outcome is the within-participant difference in systolic BP between each distraction condition and the reference BP, calculated from the mean of the two sets without distractions. Secondary outcomes include differences in diastolic BP and heart rate. Exploratory analyses will assess potential differences according to participant characteristics.

The findings will help determine whether common technological distractions influence BP measurement accuracy and inform recommendations for BP measurement in clinical, home, and research settings.

Read the detailed description

Accurate blood pressure (BP) measurement is essential for the diagnosis and management of hypertension. Current guidelines recommend standardized measurement conditions, including a period of rest and the avoidance of distractions. However, these conditions may not reflect routine clinical practice or home BP monitoring, where activities such as smartphone use or television viewing are common. The clinical impact of these technological distractions on BP measurements remains uncertain.

SCREENS-BP is a randomized crossover study designed to evaluate whether smartphone use and television viewing influence BP measurements obtained under otherwise standardized conditions. The study will recruit 96 adults aged 18 years or older.

Each participant will complete four sets of BP measurements on the non-dominant arm using a validated automated oscillometric device. Each set will include a five-minute rest period followed by three BP measurements taken at one-minute intervals, without staff present in the room. Before each set, participants will walk slowly for two minutes and then be positioned according to standardized BP measurement recommendations.

The first three measurement conditions will be performed in randomized order:

  1. Standardized BP measurement without distractions.
  2. BP measurement while actively using a smartphone.
  3. BP measurement while watching a standardized informational video on a television.

A fourth set of standardized BP measurements without distractions will be performed at the end of the protocol to account for within-participant BP variability and potential changes in BP over time.

The primary outcome will be the within-participant difference in mean systolic BP between each distraction condition and the reference BP, calculated as the average of the two standardized measurement sets. Secondary outcomes will include differences in diastolic BP and heart rate. Exploratory analyses will evaluate potential effect modification by sex, age, baseline BP, and antihypertensive medication use, as well as the robustness of the results across different statistical approaches.

By quantifying the impact of common technological distractions on BP measurements, SCREENS-BP aims to inform recommendations for BP measurement in clinical settings, at home, in pharmacies, and in research. The results may support stricter standardization of measurement conditions or provide evidence for more flexible protocols if no clinically meaningful differences are observed.

02

Conditions studied

  • Hypertension

Browse trials for

Keywords

  • blood pressure measurement
03

In context

Hypertension

6,114 studies on the registry are indexed under Hypertension; 912 are open to participants now.

This study's planned enrollment of 96 is close to the median of 100 across 4,575 interventional studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal is the lead sponsor of 34 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 years or older

Exclusion criteria

Exclusion Criteria:

  • Upper arm sizes outside of the range of the available cuffs (\<14 cm or > 52 cm)
  • Atrial fibrillation at the time of measurements
  • Ongoing pregnancy
  • No smartphone in their possession
  • Inability or unwillingness to provide consent
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
96 participants (estimated)

Study arms

  • Active comparator
    Optimal BP measurement (no dictractions) #1

    BP measured in an optimal environnement, without any distractions (first set)

    Diagnostic Test: Standardized office blood pressure measurements

  • Active comparator
    Phone

    BP measured while being being distracted by smartphone browsing

    Diagnostic Test: Standardized office blood pressure measurements

  • Active comparator
    Television

    BP measured while being being distracted by television watching

    Diagnostic Test: Standardized office blood pressure measurements

  • Active comparator
    Optimal BP measurement (no dictractions) #2

    BP measured in an optimal environnement, without any distractions (second set)

    Diagnostic Test: Standardized office blood pressure measurements

Interventions

  • Diagnostic testStandardized office blood pressure measurements

    Standardized office blood pressure measurements

06

What researchers measure

Primary outcomes

  1. Mean difference in systolic BP - Phone distraction

    Mean difference in systolic BP between BP measured during the Phone distraction and the mean of the two standardized AOBP measurement series (without any distraction)

    Time frame: At enrollment (time 0)

  2. Mean difference in systolic BP - Television distraction

    Mean difference in systolic BP between BP measured during the Television distraction and the mean of the two standardized AOBP measurement series (without any distraction)

    Time frame: At enrollment (time 0)

Secondary outcomes

  1. Mean difference in diastolic BP - Phone distraction

    Mean difference in diastolic BP between BP measured during the Phone distraction and the mean of the two standardized AOBP measurement series (without any distraction)

    Time frame: At enrollment (time 0)

  2. Mean difference in diastolic BP - Television distraction

    Mean difference in diastolic BP between BP measured during the Television distraction and the mean of the two standardized AOBP measurement series (without any distraction)

    Time frame: At enrollment (time 0)

  3. Mean difference in heart rate - Phone distraction

    Mean difference in heart rate between BP measured during the Phone distraction and the mean of the two standardized AOBP measurement series (without any distraction)

    Time frame: At enrollment (time 0)

  4. Mean difference in heart rate - Television distraction

    Mean difference in heart rate between BP measured during the Television distraction and the mean of the two standardized AOBP measurement series (without any distraction)

    Time frame: At enrollment (time 0)

Other outcomes

  1. Subgroup analysis - sex

    Subgroup analysis - sex

    Time frame: At enrollment (time 0)

  2. Subgroup analysis - Systolic BP above and below 130 mmHg

    Subgroup analysis - Systolic BP above and below 130 mmHg

    Time frame: At enrollment (time 0)

  3. Subgroup analysis - Antihypertensive use

    Subgroup analysis - Antihypertensive use

    Time frame: At enrollment (time 0)

  4. Subgroup analysis - Above and below median age

    Subgroup analysis - Above and below median age

    Time frame: At enrollment (time 0)

  5. Subgroup analysis - Above and below median habitual screen time

    Subgroup analysis - Above and below median habitual screen time

    Time frame: At enrollment (time 0)

07

Study locations

2 sites
08

References and documents

Individual participant data

Plan to share: Yes — Available upon reasonnable request

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Nov 2028, 23 months later.

Of 1,403 non-industry interventional studies with no phase under Hypertension, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 23 months is close to that.

Counting every sponsor, half of 1,498 studies reached it within 23 months; a quarter within 10 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 19, 2026
First posted
Oct 29, 2026
StartEst.
Nov 15, 2026
Primary completionEst.
Nov 14, 2028
CompletionEst.
Nov 14, 2028
Last update
Oct 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 29, 2026
Show all 1 update
  1. Oct 29, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07903779
Lead sponsor
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
Responsible party
Remi Goupil, MD MSc (Associate Professor, Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal) — Principal investigator
First posted
Oct 29, 2026
Start date
Nov 15, 2026 (estimated)
Primary completion
Nov 14, 2028 (estimated)
Completion
Nov 14, 2028 (estimated)
Last update
Oct 29, 2026

Study contacts

Remi Goupil, MD MSc
Contact
remi.goupil@umontreal.ca
+1-514-338-2883

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion